Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6308-6318
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6308
Table 2 Patient characteristics at randomization to intervention and control groups, n (%)
Rehabilitation exercise group
Control group
n = 30
n = 30
Age (yr)55 ± 958 ± 8
Infarction area, n (%)
Anterior AMI18 (60)15 (50)
Non-anterior AMI12 (40)15 (50)
History of smoking, n (%)28 (93.3)24 (80)
Concomitant disease, n (%)
Diabetic mellitus2 (6.7)3 (10)
Hypertension5 (16.6)4 (13.3)
Hypercholesteremia3 (10)4 (13.3)
Drug therapy, n (%)
Aspirin30 (100)30 (100)
Clopidogrel29 (96.7)28 (93.3)
β-receptor blocker25 (83.3)28 (93.3)
ACEI/ARB29 (96.7)27 (90)
Statins28 (93.3)29 (96.7)